A Randomized Controlled Trial Adding Fluvastatin to Peginterferon and Ribavirin for Naive Genotype One Hepatitis C Patients

被引：0
|
作者：
Bader, Ted
Hughes, L. Diane
Dunnam, Monica
Frost, Belinda
Gonterman, Andrea
Fazili, Javid
Madhoun, Mohammad F.
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S939 / S939
页数：1
相关论文
共 50 条
  • [41] 24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial
    Cai, Qingxian
    Zhang, Xiaohong
    Lin, Chaoshuang
    Shao, Xiaoqiong
    Guan, Yujuan
    Deng, Hong
    Wei, Min
    Huang, Mingshou
    Ren, Zefang
    Lu, Ling
    Mei, Yongyu
    Xu, Min
    Zhu, Jianyun
    Shi, Haiyan
    Lin, Guoli
    Liu, Ying
    Hu, Fengyu
    Luo, Qiumin
    Lan, Yun
    Guo, Fengxia
    Zhao, Zhixin
    Gao, Zhiliang
    PLOS ONE, 2015, 10 (10):
  • [42] Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study
    Suda, Goki
    Ito, Jun
    Nagasaka, Atsushi
    Yamamoto, Yoshiya
    Furuya, Ken
    Okamoto, Munenori
    Terashita, Katsumi
    Kobayashi, Tomoe
    Tsunematsu, Izumi
    Yoshida, Junichi
    Meguro, Takashi
    Ohara, Masatsugu
    Kawagishi, Naoki
    Kimura, Megumi
    Umemura, Machiko
    Izumi, Takaaki
    Tsukuda, Yoko
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    HEPATOLOGY RESEARCH, 2018, 48 (03) : E146 - E154
  • [43] Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
    Liu, Chen-Hua
    Liu, Chun-Jen
    Huang, Chung-Feng
    Lin, Jou-Wei
    Dai, Chia-Yen
    Liang, Cheng-Chao
    Huang, Jee-Fu
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Tsai, Meng-Kun
    Lee, Chih-Yuan
    Chen, Shih-I
    Yang, Sheng-Shun
    Su, Tung-Hung
    Yang, Hung-Chih
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Chuang, Wan-Long
    Yu, Ming-Lung
    Kao, Jia-Horng
    GUT, 2015, 64 (02) : 303 - 311
  • [44] METFORMIN WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN THE TREATMENT OF NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WITH INSULIN RESISTANCE (TRIC-1): FINAL RESULTS OF A RANDOMIZED AND DOUBLE-BLINDED TRIAL
    Romero-Gomez, Manuel
    Diago, Moises
    Andrade, Raul J.
    Calleja, Jose Luis
    Salmeron, Javier
    Fernandez-Rodriguez, Conrado M.
    Sola, Ricard
    Herrerias, Juan M.
    Carmona, Isabel
    Garcia-Samaniego, Javier
    Moreno-Otero, Ricardo
    Morillas, Rosa
    Ramirez, Carmen
    De la Mata, Manuel
    Giner, Pilar
    Olveira, Antonio
    Nunez, Oscar
    Jorquera, Francisco
    Duran, Santiago
    Martin-Vivaldi, Rafael
    HEPATOLOGY, 2008, 48 (04) : 380A - 380A
  • [45] Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study
    Milazzo, Laura
    Caramma, Ilaria
    Mazzali, Cristina
    Cesari, Miriam
    Olivetti, Micol
    Galli, Massimo
    Antinori, Spinello
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (04) : 735 - 740
  • [46] ANALYSIS OF CAUSES OF RESPONSE FAILURE IN NAiVE PATIENTS WITH CHRONIC HEPATITIS C RECEIVING PEGINTERFERON PLUS RIBAVIRIN
    Garcia-Retortillo, Montserrat
    Maria Morillas, Rosa
    Miquel, Mireia
    Rodriguez-Lopez, Olga
    Cirera, Isabel
    Vergara, Mercedes
    Masnou, Helena
    Dolors Gimenez, M.
    Canete, Nuria
    Gallach, Marta
    Ardevol, Merce
    Antonio Alvarez, Marco
    Montoliu, Silvia
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    HEPATOLOGY, 2009, 50 (04) : 727A - 727A
  • [47] Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial
    Mangia, Alessandra
    Minerva, Nicola
    Bacca, Donato
    Cozzolongo, Raffaele
    Ricci, Giovanni L.
    Carretta, Vito
    Vinelli, Francesco
    Scotto, Gaetano
    Montalto, Giuseppe
    Romano, Mario
    Cristofaro, Giuseppe
    Mottola, Leonardo
    Spirito, Fulvio
    Andriulli, Angelo
    HEPATOLOGY, 2008, 47 (01) : 43 - 50
  • [48] Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial
    Liu, Chen-Hua
    Liang, Cheng-Chao
    Su, Tung-Hung
    Hung, Peir-Haur
    Tsai, Hung-Bin
    Liu, Chun-Jen
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2012, 56 : 993A - 993A
  • [49] Quasispecies of hepatitis C virus genotype 1 and treatment outcome with Peginterferon and Ribavirin
    Gomes Jardim, Ana Carolina
    Tomonari Yamasaki, Lilian Hiromi
    Lopo de Queiroz, Artur Trancoso
    Bittar, Cintia
    Rebello Pinho, Joao Renato
    Aparecida Carareto, Claudia Marcia
    Rahal, Paula
    Guedes de Carvalho Mello, Isabel Maria Vicente
    INFECTION GENETICS AND EVOLUTION, 2009, 9 (04) : 689 - 698
  • [50] PROPEL: A randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naive HCV genotype 1/4 patients
    Wedemeyer, Heiner
    Jensen, Donald
    Herring, Robert, Jr.
    Ferenci, Peter
    Ma, Mang-Ming
    Zeuzem, Stefan
    Rodriguez-Torres, Maribel
    Bzowej, Natalie
    Pockros, Paul
    Vierling, John
    Ipe, David
    Munson, Marie Lou
    Chen, Ya-Chi
    Najera, Isabel
    Thommes, James
    HEPATOLOGY, 2013, 58 (02) : 524 - 537
12345